久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • EIP Pharma Initiates Neflamapimod Study americanpharmaceuticalreview
    July 10, 2019
    EIP Pharma announced the initiation of a new Phase 2 proof-of-concept study evaluating neflamapimod as a treatment for the cognitive dysfunction associated with Huntington's disease, a rare, genetically inherited disease that causes the nerve cells of ...
  • NeuroVive Initiates Second Part of its Ongoing KL1333 Phase Ia/b Clinical Study prnasia
    July 05, 2019
    NeuroVive Pharmaceutical AB?(Nasdaq Stockholm: NVP) (OTCQX: NEVPF)?today announced that the company has initiated the second part in its ongoing Phase Ia/b clinical study with KL1333 ...

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service